Veru (VERU) Competitors $3.45 -0.11 (-3.09%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$3.48 +0.03 (+0.87%) As of 09/12/2025 05:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VERU vs. MED, EL, IPAR, PBH, HLF, NUS, USNA, NATR, FTLF, and BTMDShould you be buying Veru stock or one of its competitors? The main competitors of Veru include Medifast (MED), Estee Lauder Companies (EL), Interparfums (IPAR), Prestige Consumer Healthcare (PBH), Herbalife (HLF), Nu Skin Enterprises (NUS), USANA Health Sciences (USNA), Nature's Sunshine Products (NATR), FitLife Brands (FTLF), and biote (BTMD). Veru vs. Its Competitors Medifast Estee Lauder Companies Interparfums Prestige Consumer Healthcare Herbalife Nu Skin Enterprises USANA Health Sciences Nature's Sunshine Products FitLife Brands biote Veru (NASDAQ:VERU) and Medifast (NYSE:MED) are both small-cap personal products companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability, risk and media sentiment. Do institutionals & insiders believe in VERU or MED? 47.2% of Veru shares are held by institutional investors. Comparatively, 95.5% of Medifast shares are held by institutional investors. 15.2% of Veru shares are held by company insiders. Comparatively, 2.9% of Medifast shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media prefer VERU or MED? In the previous week, Medifast had 1 more articles in the media than Veru. MarketBeat recorded 2 mentions for Medifast and 1 mentions for Veru. Veru's average media sentiment score of 1.91 beat Medifast's score of 1.70 indicating that Veru is being referred to more favorably in the media. Company Overall Sentiment Veru Very Positive Medifast Very Positive Do analysts recommend VERU or MED? Veru currently has a consensus price target of $33.33, indicating a potential upside of 866.18%. Medifast has a consensus price target of $16.50, indicating a potential upside of 18.03%. Given Veru's stronger consensus rating and higher possible upside, equities research analysts plainly believe Veru is more favorable than Medifast.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Veru 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Medifast 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is VERU or MED more profitable? Medifast has a net margin of 0.76% compared to Veru's net margin of 0.00%. Medifast's return on equity of 2.00% beat Veru's return on equity.Company Net Margins Return on Equity Return on Assets VeruN/A -143.24% -85.22% Medifast 0.76%2.00%1.50% Which has stronger valuation & earnings, VERU or MED? Medifast has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than Medifast, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVeru$16.89M2.99-$37.80M-$2.20-1.57Medifast$602.46M0.26$2.09M$0.3243.68 Which has more risk and volatility, VERU or MED? Veru has a beta of -0.74, indicating that its share price is 174% less volatile than the S&P 500. Comparatively, Medifast has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500. SummaryMedifast beats Veru on 10 of the 16 factors compared between the two stocks. Get Veru News Delivered to You Automatically Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VERU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VERU vs. The Competition Export to ExcelMetricVeruMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$52.18M$10.83B$5.87B$10.13BDividend YieldN/A1.84%5.68%4.60%P/E Ratio-1.5721.1374.5225.93Price / Sales2.9930.25517.44183.79Price / CashN/A24.8137.5660.44Price / Book1.563.5212.166.29Net Income-$37.80M$210.50M$3.28B$270.77M7 Day Performance2.37%-0.18%0.87%3.88%1 Month Performance1.17%1.09%4.96%4.88%1 Year Performance-58.24%-10.96%60.75%26.01% Veru Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VERUVeru2.5261 of 5 stars$3.45-3.1%$33.33+866.2%-58.7%$52.18M$16.89M-1.57230Positive NewsMEDMedifast4.0181 of 5 stars$13.81+1.9%$16.50+19.5%-25.4%$151.74M$602.46M43.15870ELEstee Lauder Companies4.2246 of 5 stars$88.83-0.4%$87.80-1.2%-0.5%$31.97B$14.33B-28.2957,000Trending NewsAnalyst RevisionIPARInterparfums4.3303 of 5 stars$113.73+0.6%$162.00+42.4%-7.8%$3.65B$1.45B22.79530News CoveragePositive NewsPBHPrestige Consumer Healthcare4.3469 of 5 stars$65.68+1.0%$93.33+42.1%-13.3%$3.23B$1.14B15.42540Positive NewsHLFHerbalife4.2166 of 5 stars$9.85-0.1%$11.50+16.7%+31.1%$1.02B$4.93B3.118,600Positive NewsNUSNu Skin Enterprises3.6332 of 5 stars$11.53+0.3%$6.88-40.3%+59.2%$570.46M$1.63B5.733,100USNAUSANA Health Sciences4.0108 of 5 stars$30.90-2.9%$36.00+16.5%-19.8%$564.54M$854.50M17.171,700Positive NewsNATRNature's Sunshine Products3.6313 of 5 stars$17.14flat$19.67+14.7%+28.0%$302.35M$454.36M23.16850Positive NewsFTLFFitLife Brands4.3409 of 5 stars$19.13+2.1%$23.00+20.2%+5.0%$179.63M$64.47M22.7720Positive NewsBTMDbiote3.0367 of 5 stars$3.45-0.3%$6.00+73.9%-41.2%$171.06M$199.07M3.83194Positive News Related Companies and Tools Related Companies MED Alternatives EL Alternatives IPAR Alternatives PBH Alternatives HLF Alternatives NUS Alternatives USNA Alternatives NATR Alternatives FTLF Alternatives BTMD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VERU) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veru Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veru With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
